United States S 2543: Prescription Drug Pricing Reduction Act of 2019

Status: Introduced in Senate (as of 2019-09-25)

State: United States · Session: 116 · Bill: S 2543

Subjects: Accounting and auditing, Administrative law and regulatory procedures, Appropriations, Congressional oversight, Department of Health and Human Services, Drug safety, medical device, and laboratory regulation, Drug therapy, Fraud offenses and financial crimes, Genetics, Government information and archives, Government studies and investigations, Health care costs and insurance, Health care coverage and access, Health care quality, Health technology, devices, supplies, Home and outpatient care, Hospital care, Indian social and development programs, Inflation and prices, Intergovernmental relations, Manufacturing, Medicaid, Medical ethics, Medicare, Minority health, Prescription drugs, Public contracts and procurement, Public participation and lobbying, Retail and wholesale trades, Social work, volunteer service, charitable organizations, State and local government operations

Sponsors: CHARLES ERNEST GRASSLEY

View United States S 2543 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.